PMV PHARMACEUTICALS INC's ticker is PMVP and the CUSIP is 69353Y103. A total of 107 filers reported holding PMV PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $764,369 | -2.1% | 124,490 | -0.2% | 0.00% | – |
| Q2 2023 | $780,860 | +33.6% | 124,738 | +1.8% | 0.00% | – |
| Q1 2023 | $584,420 | -45.3% | 122,520 | -0.2% | 0.00% | – |
| Q4 2022 | $1,068,351 | -26.7% | 122,799 | +0.3% | 0.00% | – |
| Q3 2022 | $1,457,000 | -2.3% | 122,453 | +17.0% | 0.00% | – |
| Q2 2022 | $1,492,000 | -10.6% | 104,677 | +30.6% | 0.00% | – |
| Q1 2022 | $1,669,000 | -10.1% | 80,149 | -0.3% | 0.00% | – |
| Q4 2021 | $1,857,000 | -19.5% | 80,363 | +3.9% | 0.00% | – |
| Q3 2021 | $2,306,000 | +2.8% | 77,376 | +17.8% | 0.00% | – |
| Q2 2021 | $2,244,000 | +68.8% | 65,710 | +62.6% | 0.00% | – |
| Q1 2021 | $1,329,000 | -47.7% | 40,413 | -2.1% | 0.00% | -100.0% |
| Q4 2020 | $2,540,000 | – | 41,294 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,614,911 | $23,012,000 | 42.78% |
| Euclidean Capital LLC | 2,336,909 | $33,301,000 | 28.32% |
| OUP Management Co., LLC | 989,232 | $14,097,000 | 19.40% |
| Nextech Invest Ltd. | 1,385,807 | $19,748,000 | 6.66% |
| Boxer Capital, LLC | 3,498,636 | $49,856,000 | 3.16% |
| PERSONAL CFO SOLUTIONS, LLC | 550,342 | $7,842,000 | 1.84% |
| Orbimed Advisors | 6,563,077 | $93,524,000 | 1.70% |
| RTW INVESTMENTS, LP | 4,395,677 | $62,638,000 | 1.62% |
| ACUTA CAPITAL PARTNERS, LLC | 152,500 | $2,173,000 | 1.21% |
| Avoro Capital Advisors LLC | 3,100,000 | $44,175,000 | 0.87% |